„Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway". Nigerian Journal of Physiological Sciences, roč. 40, č. 2, prosinec 2025, s. 251-62, https://doi.org/10.54548/.